Paul K Paik (Paul Paik)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Health Information

Tyrosine Kinase

Epidermal Growth Factor Receptor

Radiation Induced

Top Venues

Hepatology communications

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hiba G Narvel, So Yeon Kim, Aspan M Shokrekhuda, Perry R Cohen, K H Ramesh, Sheila R Solomon, Paul K Paik, Balazs Halmos
Orthogonal Testing Unravels a Novel ROS1 Oncogenic Fusion Variant ( ROS1-GPM6A ): A Practical Approach to Molecular Testing for Actionable Fusion Variants. JCO precision oncology 7 (2023)
Adam Buckholz, Lindsay Clarke, Paul K Paik, Arun B Jesudian, Robert E Schwartz, Ana C Krieger, Russell E Rosenblatt, Robert S Brown
Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study. Hepatology communications 7 (2) (2023)
Paul K Paik, Ravi K Goyal, Beilei Cai, Mark A Price, Keith L Davis, Valerie Derrien Ansquer, Nydia Caro, Teddy R Saliba
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib. Future oncology (London, England) (2023)
Adam Buckholz, Lindsay Clarke, Paul K Paik, Arun B Jesudian, Robert E Schwartz, Ana C Krieger, Russell E Rosenblatt, Robert S Brown
Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study. Hepatology communications 7 (2) (2023)
Adam Buckholz, Lindsay Clarke, Paul K Paik, Arun B Jesudian, Robert E Schwartz, Ana C Krieger, Russell E Rosenblatt, Robert S Brown
Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study. Hepatology communications 7 (2) (2023)
Adam Buckholz, Lindsay Clarke, Paul K Paik, Arun B Jesudian, Robert E Schwartz, Ana C Krieger, Russell E Rosenblatt, Robert S Brown
Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study. Hepatology communications 7 (2) (2023)
Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G Kris, Gregory J Riely, Franziska Michor, Helena Alexandra Yu
Brief report: Combination of Osimertinib and Dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Adam Buckholz, Lindsay Clarke, Paul K Paik, Arun B Jesudian, Robert E Schwartz, Ana C Krieger, Russell E Rosenblatt, Robert S Brown
Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study. Hepatology communications 7 (2) (2023)
Adam Buckholz, Lindsay Clarke, Paul K Paik, Arun B Jesudian, Robert E Schwartz, Ana C Krieger, Russell E Rosenblatt, Robert S Brown
Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study. Hepatology communications 7 (2) (2023)
Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G Kris, Gregory J Riely, Franziska Michor, Helena Alexandra Yu
Brief report: Combination of Osimertinib and Dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Paul K Paik, Jia Luo, Ni Ai, Rachel Kim, Linda Ahn, Anup Biswas, Courtney Coker, Wanchao Ma, Phillip Wong, Darren J Buonocore, W Victoria Lai, Jamie E Chaft, Swarnali Acharyya, Joan Massagué, Mark G Kris
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas. Nature communications 13 (1) (2022)
Hiroki Sato, Daisuke Kubota, Huan Qiao, Achim Jungbluth, Natasha Rekhtman, Adam J Schoenfeld, Helena Alexandra Yu, Gregory J Riely, Shinichi Toyooka, Christine M Lovly, Paul K Paik, Marc Ladanyi, Pang-Dian Fan
SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors. JCO precision oncology 6 (2022)
Xiuning Li, Lingzhi Hong, Charles H Hensel, Rongrong Chen, Haley Kemp, Niamh Coleman, Christine A Ciunci, Stephen V Liu, Marcelo V Negrao, Jennifer Yen, Xuefeng Xia, Juergen Scheuenpflug, Christopher Stroh, Dilafruz Juraeva, Anne S Tsao, David S Hong, Victoria M Raymond, Paul K Paik, Jianjun Zhang, John V Heymach
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring MET Exon 14 Skipping. JCO precision oncology 5 (2021)